marketupdatenews


SUBMITTED BY: marketupdatenews

DATE: July 4, 2022, 9:05 a.m.

FORMAT: Text only

SIZE: 3.0 kB

HITS: 426

  1. Anti-Viral Therapies Market Company Profiles, Market Segments, Landscape 2027
  2. Market Overview:
  3. According to our new market research study on “Anti-Viral Therapies Market to 2027 - Global Analysis and Forecast - by Type, Mechanism of Action, and End User,” the market is expected to reach US$ 76,282.63 million by 2027 from US$ 40,589.79 million in 2019; it is estimated to grow at a CAGR of 8.3% from 2020 to 2027. The report highlights trends prevailing in the global anti - viral therapies market and the drivers and restraints pertaining to the market growth.
  4. Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00012650/
  5. Based on type, the global anti - viral therapies market is segmented into generic drugs and branded drugs. The generic drugs segment is estimated to register a higher CAGR in the market during 2020–2027. Rising demand for low-cost drugs, growing number of FDA-approved generic drugs, rising adoption in emerging nations, and patent expiry of various branded products are the factors boosting the market for the generic drugs segment.
  6. The global anti - viral therapies market growth is mainly attributed to factors such as increasing R&D expenditure in pharmaceutical companies and rising government support for research activities and clinical trials. However, high drug development cost hinders the growth of the market.
  7. AbbVie Inc.; Abbott; Astrazeneca; F. Hoffmann-La Roche Ltd; Bristol-Myers Squibb Company; Johnson & Johnson Services, Inc.; Merck & Co., Inc.; Gilead Sciences, Inc.; GlaxoSmithKline plc; and Aurobindo Pharma are among the leading companies operating in the anti - viral therapies market.
  8. Buy Now: https://www.theinsightpartners.com/buy/TIPRE00012650/
  9. The Report Segments Global Anti - Viral Therapies Market as Follows:
  10. By Type
  11. Generic Drugs
  12. Branded Drugs
  13. By Mechanism of Action
  14. Nucleotide Polymerase Inhibitors
  15. Reverse Transcriptase Inhibitors
  16. Protease Inhibitors
  17. Others
  18. By Application
  19. HIV
  20. Hepatitis
  21. Herpes
  22. Virus Influenza
  23. Other Applications
  24. By Geography
  25. North America
  26. US
  27. Canada
  28. Mexico
  29. Europe
  30. France
  31. Germany
  32. UK
  33. Spain
  34. Italy
  35. Asia Pacific (APAC)
  36. China
  37. India
  38. Japan
  39. Australia
  40. South Korea
  41. Middle East and Africa (MEA)
  42. Saudi Arabia
  43. UAE
  44. South Africa
  45. South and Central America (SCAM)
  46. Brazil
  47. Argentina
  48. About Us:
  49. The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
  50. Contact Us:
  51. If you have any queries about this report or if you would like further information, please contact us:
  52. Contact Person: Sameer Joshi
  53. E-mail: sales@theinsightpartners.com
  54. Phone: +1-646-491-9876

comments powered by Disqus